Aegerion Pharmaceuticals (AEGR) Leaps on QLT Deal

Aegerion Pharmaceuticals, Inc.

shares soared 35.9% to $1.78, on news the company and QLT Inc. have entered into a definitive merger agreement under which Aegerion will be merged with a wholly owned indirect subsidiary of QLT. Share volume was 7.5 million, compared to an all-day average of 819,000